SIGNAL GENETICS
Signal Genetics, Inc., is a commercial-stage, molecular diagnostics company providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences (UAMS). More than 30 years of clinical research on nearly 10,000 multiple myeloma patients who received their care at UAMS went into the development of Signal Genetics’ flagship product, MyPRS® (Myeloma Prognostic Risk Signature).
SIGNAL GENETICS
Social Links:
Industry:
Health Care Health Diagnostics Innovation Management
Founded:
2010-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.signalgenetics.com
Total Employee:
51+
Status:
Active
Contact:
+1 760-537-4100
Total Funding:
25 M USD
Technology used in webpage:
SPF Apache Mobile Non Scaleable Content PHP Apache 2.4 DigiCert SSL CloudFront AWS Global Accelerator OpenSSL New Relic
Current Employees Featured
Stock Details
Investors List
BSL Capital
BSL Capital investment in Convertible Note - Signal Genetics
BSL Capital
BSL Capital investment in Seed Round - Signal Genetics
Myeloma Institute for Research and Therapy UAMS
Myeloma Institute for Research and Therapy UAMS investment in Seed Round - Signal Genetics
Official Site Inspections
http://www.signalgenetics.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
